Non-antibody immunotherapy of cancer Journal Article


Authors: Chapman, P. B.; Houghton, A. N.
Article Title: Non-antibody immunotherapy of cancer
Abstract: Immunotherapeutic agents have become important additions to the list of anti-cancer treatments; further progress will require more information about how the immune system can respond to tumor cells. Tumor cells can avoid eliciting an immune response through several mechanisms. Understanding these mechanisms may suggest strategies to manipulate tumor cells so that they trigger an effective immune response. Another strategy being developed is to improve the therapeutic index of cytokines so that better anti-tumor effects can be elicited with less toxicity. © 1993.
Keywords: review; drug safety; alpha interferon; neoplasms; animal; bcg vaccine; interleukin 2; cancer immunotherapy; cytokine; cytokines; immune response; immunotherapy; antigens, neoplasm; pentoxifylline; tumor cell; immunomodulating agent; cell activity; antibodies, neoplasm; tumor necrosis factor; immunization; granulocyte-macrophage colony-stimulating factor; cancer; human
Journal Title: Current Opinion in Immunology
Volume: 5
Issue: 5
ISSN: 0952-7915
Publisher: Elsevier Inc.  
Date Published: 1993-10-01
Start Page: 726
End Page: 731
Language: English
DOI: 10.1016/0952-7915(93)90128-f
PUBMED: 8240734
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman
  2. Alan N Houghton
    364 Houghton